Fenbendazole For Humans Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

VINATURA is the best-performing fenbendazole for humans brand in July 2026, moving 10,000 units across 1 ASIN for 31.3% of Top 10 volume. Zahler follows with 8,000 units (25.0%), ahead of VivoNu on 4,000 units (12.5%).

With 9 brands splitting the Top 10 and 68.8% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $12.99 to $29.70, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, 2 ASINs forced its way in: B01N8QFT5B booked 1K units at $43.00, with ▲ 11.1% MoM change. On the growth side, B0GWMMC6JF leads positive momentum with ▲ 700.0% MoM growth on 400 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.